Tribune OnlineCEPI invests over $250m to develop Lassa fever vaccineThe Coalition for Epidemic Preparedness Innovations (CEPI) has disclosed that a significant amount of over $250 million has been invested to develop Lassa fever vaccine to combat a highly infectious and often deadly virus prevalent in West Africa. It said the substantial investment will support the development of a Lassa fever vaccine and fund research [...]CEPI invests over $250m to develop Lassa fever vaccineTribune Online
Related Articles
Don't miss out on breaking stories and in-depth articles.